Skip to main navigation Skip to search Skip to main content

High-quality NMR structure of human anti-apoptotic protein domain Mcl-1(171-327) for cancer drug design

  • Gaohua Liu
  • , Leszek Poppe
  • , Ken Aoki
  • , Harvey Yamane
  • , Jeffrey Lewis
  • , Thomas Szyperski
  • SUNY Buffalo
  • Rutgers - The State University of New Jersey, New Brunswick
  • Amgen Incorporated

Research output: Contribution to journalArticlepeer-review

29 Scopus citations

Abstract

A high-quality NMR solution structure is presented for protein hMcl-1(171-327) which comprises residues 171-327 of the human anti-apoptotic protein Mcl-1 (hMcl-1). Since this construct contains the three Bcl-2 homology (BH) sequence motifs which participate in forming a binding site for inhibitors of hMcl-1, it is deemed to be crucial for structure-based design of novel anti-cancer drugs blocking the Mcl1 related anti-apoptotic pathway. While the coordinates of an NMR solution structure for a corresponding construct of the mouse homologue (mMcl-1) are publicly available, our structure is the first atomic resolution structure reported for the 'apo form' of the human protein. Comparison of the two structures reveals that hMcl-1(171-327) exhibits a somewhat wider ligand/inhibitor binding groove as well as a different charge distribution within the BH3 binding groove. These findings strongly suggest that the availability of the human structure is of critical importance to support future design of cancer drugs.

Original languageEnglish
Article numbere96521
JournalPLOS ONE
Volume9
Issue number5
DOIs
StatePublished - May 2 2014

Fingerprint

Dive into the research topics of 'High-quality NMR structure of human anti-apoptotic protein domain Mcl-1(171-327) for cancer drug design'. Together they form a unique fingerprint.

Cite this